Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net loss $ (159,321) $ (982,714)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 210,676 195,464
(Gain) loss on derivatives 4,404 (19,779)
Loss on extinguishment of debt 2,434 188,433
Provision for bad debts and inventory obsolescence 1,199 1,294
Share-based compensation expense 28,155 32,792
Net foreign currency adjustments 1,021 (4,126)
Changes in operating assets and liabilities:    
Accounts receivable, net 65,391 618,853
Inventories 2,812 (24,141)
Prepaid expenses and other assets (127,192) (632,610)
Accounts payable (25,926) (136,767)
Accrued expenses and other liabilities (168,581) (25,587)
Advance ticket sales 668,261 417,877
Net cash provided by (used in) operating activities 503,333 (371,011)
Cash flows from investing activities    
Additions to property and equipment, net (237,676) (165,284)
Proceeds from maturities of short-term investments   240,000
Other, net 1,320 4,940
Net cash provided by (used in) investing activities (236,356) 79,656
Cash flows from financing activities    
Repayments of long-term debt (1,821,412) (935,444)
Proceeds from long-term debt 1,330,622 2,073,175
Proceeds from employee related plans 2,618 2,557
Net share settlement of restricted share units (11,306) (11,961)
Early redemption premium   (172,012)
Deferred financing fees (13,886) (34,767)
Net cash provided by (used in) financing activities (513,364) 921,548
Net increase (decrease) in cash and cash equivalents (246,387) 630,193
Cash and cash equivalents at beginning of period 946,987 1,506,647
Cash and cash equivalents at end of period $ 700,600 $ 2,136,840